ESG

Medical supply giant Medline closes 2025's largest IPO, raising billions to slash debt and fuel growth, cementing its dominance in the healthcare sector.

A Minnesota startup has secured major funding to advance its bioelectronic device aimed at the brain's waste clearance system for treating CNS disorders.

Eight top US students will join a fully funded internship in Copenhagen to learn from Denmark's world-class sustainability, forging a new path for green careers.

A simple, low-cost heart pill may hold the key to treating Alzheimer's and kidney disease. CardioPharma is now funding research to unlock its potential.

A new report projects a staggering $47T cost from chronic illness by 2039. Experts say prevention and innovation could save trillions and 13.5M lives.

Syra Health appoints Gregory R. Alexander as CEO, banking on his military discipline and record of scaling healthcare firms to drive its next growth phase.

Get ready for a car that knows you. Cinemo's agentic AI promises hyper-personalized rides, blurring the lines between your vehicle and your digital life.

RELEX Solutions' strategic acquisition of Ida aims to revolutionize fresh food management, promising less waste, higher sales, and a smarter supply chain.

A major partnership brings high-tech, locally grown organic herbs to Mid-Atlantic shelves, aiming to slash food miles and redefine retail freshness.

Avantor appoints financial heavyweight Simon Dingemans to its board, a strategic move to accelerate its ambitious turnaround amid market pressures.

A breakthrough genetic test helps prostate cancer patients avoid severe side effects from radiation while saving the healthcare system millions of dollars.

With trial data showing an average 23% body weight loss, Novo Nordisk's new combination drug CagriSema could usher in a powerful new era for medicine.

Pharma giant GSK partners with biotech CAMP4, leveraging novel RNA-boosting tech to develop new therapies for neurodegenerative and kidney diseases.

An eight-figure deal for Redwire's docking systems is set to equip The Exploration Company's Nyx capsule, marking a key step for European space autonomy.

With a massive potential loan, the U.S. government is backing a plan to mine in Alaska and manufacture in Ohio, aiming to end its reliance on foreign graphite.

The neuro-focused biotech just acquired a late-stage cancer drug, securing massive funding. Is this a brilliant diversification or a high-stakes gamble?

With FDA approval for a pivotal study, Pulse Biosciences' novel nanosecond ablation technology aims to make atrial fibrillation treatment safer and more precise.

A new partnership aims to build a secure battery supply chain for drones and UAMs, directly responding to US defense restrictions on Chinese tech.

Exceptional drill results reveal high-grade copper and gold, potentially reshaping the economics of NorthWest's key British Columbia mining asset.

A massive order for a new South American copper mine highlights the critical link between advanced mining technology and the world's green energy needs.